CAVALLARO, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 5.829
AS - Asia 5.117
NA - Nord America 3.356
SA - Sud America 1.135
AF - Africa 116
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.584
Nazione #
US - Stati Uniti d'America 3.188
RU - Federazione Russa 3.060
SG - Singapore 1.899
CN - Cina 1.609
BR - Brasile 933
IT - Italia 733
SE - Svezia 659
HK - Hong Kong 635
VN - Vietnam 482
FR - Francia 284
RO - Romania 268
DE - Germania 222
GB - Regno Unito 175
IN - India 126
CA - Canada 89
FI - Finlandia 87
AR - Argentina 80
NL - Olanda 63
BD - Bangladesh 56
ES - Italia 51
MX - Messico 51
IE - Irlanda 49
PL - Polonia 49
TR - Turchia 44
ID - Indonesia 41
CO - Colombia 37
AT - Austria 32
ZA - Sudafrica 31
JP - Giappone 30
EC - Ecuador 29
IR - Iran 27
IQ - Iraq 25
KR - Corea 22
AU - Australia 20
UA - Ucraina 18
EG - Egitto 16
MA - Marocco 16
PE - Perù 16
PK - Pakistan 16
TN - Tunisia 15
MY - Malesia 14
CL - Cile 13
PY - Paraguay 12
UZ - Uzbekistan 11
VE - Venezuela 11
BE - Belgio 10
LT - Lituania 10
PT - Portogallo 10
PH - Filippine 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
DK - Danimarca 7
IL - Israele 7
JM - Giamaica 7
JO - Giordania 7
NP - Nepal 7
NZ - Nuova Zelanda 7
RS - Serbia 7
CH - Svizzera 6
KE - Kenya 6
DO - Repubblica Dominicana 5
LB - Libano 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
OM - Oman 4
SC - Seychelles 4
TH - Thailandia 4
GR - Grecia 3
HR - Croazia 3
KZ - Kazakistan 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
LY - Libia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
Totale 15.567
Città #
Singapore 804
Moscow 684
Hong Kong 617
Dallas 466
Ashburn 437
San Jose 430
Shanghai 326
Hefei 240
Beijing 215
Princeton 213
Lawrence 212
Lauterbourg 211
Ho Chi Minh City 176
Milan 154
New York 136
Hanoi 105
São Paulo 102
Munich 78
Los Angeles 74
Boardman 60
Helsinki 58
Orem 53
Rome 51
Dublin 47
Montreal 37
The Dalles 35
Warsaw 35
Chennai 33
Santa Clara 33
Frankfurt am Main 30
Council Bluffs 28
Atlanta 27
Rio de Janeiro 27
Tokyo 27
Brooklyn 26
Denver 26
London 26
Poplar 26
Stockholm 26
Da Nang 25
Pune 23
Turku 23
Amsterdam 22
Nuremberg 22
Belo Horizonte 21
Guangzhou 20
Johannesburg 20
Phoenix 20
Seattle 20
Brasília 19
Manchester 19
San Francisco 19
Houston 18
Naples 18
Pittsburgh 18
Turin 18
Ankara 17
Vienna 17
Haiphong 16
Mexico City 16
Toronto 15
Boston 14
Curitiba 14
Genoa 14
Tianjin 13
Chicago 12
Salvador 12
Bogotá 11
City of London 11
Guarulhos 11
Washington 11
Biên Hòa 10
Bologna 10
Bắc Ninh 10
Cairo 10
Dhaka 10
Fortaleza 10
Istanbul 10
Quito 10
Campinas 9
Kuala Lumpur 9
Lima 9
Mumbai 9
Secaucus 9
Apodaca 8
Baghdad 8
Brescia 8
Buenos Aires 8
Changsha 8
Jakarta 8
Can Tho 7
Columbus 7
Dalian 7
Lentate sul Seveso 7
Manaus 7
Miami 7
New Delhi 7
Shenzhen 7
Tashkent 7
Volta Redonda 7
Totale 7.183
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 375
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 230
Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences 221
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 146
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 143
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 136
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 131
The cognitive architecture of verbal humor in schizophrenia 122
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 121
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 119
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 113
Adult Consequences of Neurodevelopmental Disorders 111
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 111
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 108
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 108
Psychotic Disorders 106
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 106
ANTIPSYCHOTIC-INDUCED TARDIVE-DYSKINESIA - RECOGNITION, PREVENTION AND MANAGEMENT 105
Cogpack®: presupposti, descrizione e metodi a confronto",La riabilitazione cognitiva della schizofrenia 105
Cognitive reserve profiles are associated with outcome in schizophrenia 102
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 102
A PILOT, OPEN STUDY ON THE TREATMENT OF REFRACTORY SCHIZOPHRENIA WITH RISPERIDONE AND CLOZAPINE 100
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 99
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 99
Amygdala and the anterior cyngulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla bold FMRI study 97
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 97
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 96
Cognitive remediation in schizophrenia: What happens after 10 years? 96
Adverse childhood experiences influence white matter microstructure in patients with schizophrenia 96
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 96
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. XXVI Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), Munich 13-17 July. 95
The role of agency in schizophrenia: A pilot study on gaze agency 94
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 93
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 92
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. 92
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 91
Organic Mental Disorders and Psychiatric Issues in the Elderly 90
ADDing a piece to the puzzle of cognition in schizophrenia 90
Adverse childhood experiences influence the detrimental effect of bipolar disorder and schizophrenia on cortico-limbic grey matter volumes 90
Targeting social cognition to improve functional outcome of patients with schizophrenia: Clinical evidences 90
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 90
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 89
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 88
Non-Pharmacological Treatments 88
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 88
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 87
Antiprostatic effect of cimetidine in rats. 86
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 86
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 85
Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind 84
Psychopathology 84
The brief assessment of cognition in schizophrenia. Normative data for the Italian population 83
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 83
Belief Inflexibility and Cognitive Biases in Anorexia Nervosa—The Role of the Bias against Disconfirmatory Evidence and Its Clinical and Neuropsychological Correlates 81
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 81
Antipsicotici 80
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 80
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 80
A functional comparison of patients with schizophrenia between the North and South of Europe 79
A flexible-dose study of paliperidone ER in patients with non-acute schizophrenia previously unsuccessfully treated with oral risperidone 78
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 76
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive rernediation in schizophrenia 76
Abnormal cortico-limbic connectivity during emotional processing correlates with symptom severity in schizophrenia 75
Cogpack®: prove di efficacia,La riabilitazione cognitiva della schizofrenia 74
Analysis of three polymorphisms of the 5HT2a receptor gene in patients with tardive dyskinesia. 74
Psicopatologia e semeiotica della depressione: strumenti di valutazione 73
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 73
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 72
Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms 72
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 71
Obesity influences white matter integrity in schizophrenia 71
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 71
Smooth pursuit eye movements and saccadic eye movements in patients with delusional disorder 69
Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study 68
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 68
Basi biologiche e trattamento della schizofrenia e del disturbo delirante 68
Psychedelics and schizophrenia: a double-edged sword 68
Unmet needs in the treatment of schizophrenia: The role of aripiprazole [Bisogni irrisolti nel trattamento della schizofrenia: Ruolo di aripiprazolo] 67
Substance-Related Disorders 66
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations 66
Reality monitoring and paranoia in remitted delusional depression. 66
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. 65
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 65
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 64
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity 64
VALUTAZIONI DEL FUNZIONAMENTO COGNITIVO “TRASFERIBILI” ALLA PRATICA CLINICA: LA BRIEF ASSESSMENT OF COGNITION SCALE (BACS) E LA SCHIZOPHRENIA COGNITION RATING SCALE (SCORS) 63
Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances 62
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 61
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 61
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 60
Navigating the Complexity of Psychotic Disorders: A Systematic Review of EEG Microstates and Machine Learning 60
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 60
Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour 60
Neuroleptic-induced extrapyramidal side effects. I: Tardive dyskinesia [GLI EFFETTI COLLATERALI EXTRAPIRAMIDALI INDOTTI DA NEUROLETTICI. I: LA DISCINESIA TARDIVA] 59
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 59
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 59
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art 59
Haloperidol metabolism and clinical outcome in schizophrenic patients 58
Pragmatic abilities across symptoms dimensions in schizophrenia 58
Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence 58
Totale 9.033
Categoria #
all - tutte 95.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 2 0 0
2021/2022149 0 0 0 41 20 9 9 12 16 9 15 18
2022/20231.359 493 256 87 15 47 172 50 95 70 26 21 27
2023/2024787 53 47 85 72 81 131 20 71 6 30 54 137
2024/20253.661 450 94 76 167 100 264 627 227 642 424 295 295
2025/20269.731 810 798 586 1.407 801 294 1.077 717 2.793 448 0 0
Totale 15.765